The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000–15: an analysis of pharmaceutical sales data
Abstract
Background The WHO Access, Watch, and Reserve (AWaRe) antibiotic classification framework aims to balance appropriate access to antibiotics and stewardship. We aimed to identify how patterns of antibiotic consumption in each of the AWaRe categories changed across countries over 15 years. Methods Antibiotic consumption was classified into Access, Watch, and Reserve categories for 76 countries between 2000, and 2015, using quarterly national sample survey data obtained from IQVIA. We measured the proportion of antibiotic use in each category, and calculated the ratio of Access antibiotics to Watch antibiotics (access-to-watch index), for each country. Findings Between 2000, and 2015, global per-capita consumption of Watch antibiotics increased by 90·9% (from 3·3 to 6·3 defined daily doses per 1000 inhabitants per day [DIDs]) compared with an increase of 26·2% (from 8·4 to 10·6 DIDs) in Access antibiotics. The increase in Watch antibiotic consumption was greater in low-income and middle-income countries (LMICs; 165·0%; from 2·0 to 5·3 DIDs) than in high-income countries (HICs; 27·9%; from 6·1 to 7·8 DIDs). The access-to-watch index decreased by 38·5% over the study period globally (from 2·6 to 1·6); 46·7% decrease in LMICs (from 3·0 to 1·6) and 16·7% decrease in HICs (from 1·8 to 1·5), and 37 (90%) of 41 LMICs had a decrease in their relative access-to-watch consumption. The proportion of countries in which Access antibiotics represented at least 60% of their total antibiotic consumption (the WHO national-level target) decreased from 50 (76%) of 66 countries in 2000, to 42 (55%) of 76 countries in 2015. Interpretation Rapid increases in Watch antibiotic consumption, particularly in LMICs, reflect challenges in antibiotic stewardship. Without policy changes, the WHO national-level target of at least 60% of total antibiotic consumption being in the Access category by 2023, will be difficult to achieve. The AWaRe framework is an important measure of the effort to combat antimicrobial resistance and to ensure equal access to effective antibiotics between countries. Funding US Centers for Disease Control and Prevention.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The predominance of Access-group antibiotics suggests partial alignment with stewardship-oriented prescribing 28,29,31,32 , whereas the proportion of Watch-group use indicates potential scope for optimization 31-33 .”
From Outpatient Antibiotic Prescribing and Stewardship in South India: AnalysisUsing WHO/INRUD Indicators and AWaRe Classification (2026) · cites this paper as [29]
Citations
Cites
Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
Klein, E. Y., Van Boeckel, T. P., Martinez, E. M., Pant, S., Gandra, S., Levin, S. A., Goossens, H., & Laxminarayan, R. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717295115 · Cited by 3,232
Self-citationThe threat of antimicrobial resistance in developing countries: causes and control strategies
Ayukekbong, J. A., Ntemgwa, M., & Atabe, A. N. (2017) · Antimicrobial Resistance & Infection Control · doi:10.1186/s13756-017-0208-x · Cited by 1,315
Antibiotic prescribing for adults in ambulatory care in the USA, 2007–09
Shapiro, D. J., Hicks, L. A., Pavia, A. T., & Hersh, A. L. (2013) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkt301 · Cited by 476
Hsia, Y., Lee, B. R., Versporten, A., Yang, Y., Bielicki, J. A., Jackson, C., Newland, J. G., Goossens, H., Magrini, N., Sharland, M., et al. (2019) · The Lancet Global Health · doi:10.1016/s2214-109x(19)30071-3 · Cited by 350
Self-citationVersporten, A., Bolokhovets, G., Ghazaryan, L., Abilova, V., Pyshnik, G., Spasojevic, T., Korinteli, I., Raka, L., Kambaralieva, B., Čizmović, L., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)70071-4 · Cited by 290
Goossens, H., Ferech, M., Coenen, S., Stephens, P., & European Surveillance of Antimicrobial Consumption Project Group (2007) · Clinical Infectious Diseases · doi:10.1086/512810 · Cited by 226
Hsia, Y., Sharland, M., Jackson, C., Wong, I. C. K., Magrini, N., & Bielicki, J. A. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30547-4 · Cited by 206
Self-citationMendelson, M., Røttingen, J., Gopinathan, U., Hamer, D. H., Wertheim, H. F. L., Basnyat, B., Butler, C., Tomson, G. B., & Balasegaram, M. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00547-4 · Cited by 205
Tracking global trends in the effectiveness of antibiotic therapy using the Drug Resistance Index
Klein, E. Y., Tseng, K. K., Pant, S., & Laxminarayan, R. (2019) · BMJ Global Health · doi:10.1136/bmjgh-2018-001315 · Cited by 178
Self-citationGebretekle, G. B., Mariam, D. H., Abebe, W., Amogne, W., Tenna, A., Fenta, T. G., Libman, M., Yansouni, C. P., & Semret, M. (2018) · PLoS ONE · doi:10.1371/journal.pone.0208447 · Cited by 133
Cited by
Sorted by citations
Items 301–400 of 501
Alsaleh, N. A., Alsmari, A., Alhameed, A. F., Alenazi, A. O., Alsharif, A. A., Ben-Akresh, A., Alnakhli, A. M., Alshehail, B., Alzahrani, E. A., Alshehri, G. H., et al. (2025) · Journal of Global Antimicrobial Resistance · doi:10.1016/j.jgar.2025.09.009 · Cited by 5
Lesbani, A., Ahmad, N., Wijaya, A., Sayeri, R. J., Aliyah, A. S., Ramadhan, N., Komis, Arieveali, H., Amri, & Hanifah, Y. (2026) · Next Materials · doi:10.1016/j.nxmate.2026.102125 · Cited by 4
Environmental and lifestyle drivers of early-onset cancer
Hamada, T., Inamura, K., Ben‐Aharon, I., Ugai, T., & Ogino, S. (2026) · Nature Health · doi:10.1038/s44360-026-00122-0 · Cited by 4
Gustafsson, L., Nazzal, Z. A. S., Wiskin, C., Belkebir, S., Sayeed, S., & Wood, A. (2024) · JAC-Antimicrobial Resistance · doi:10.1093/jacamr/dlae198 · Cited by 4
Sefah, I. A., Dzonu, I. R., Korbuvi, J., Alalbila, T. M., Alqifari, S. F., Kurdi, A. B., Godman, B., & Bangalee, V. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10967-7 · Cited by 4
Nguyen-Thi, H.-Y., Bui, T. V., Tran-Thi, H.-N., Le, A. D. M., Nguyen, B. D. G., Tran-Thi, H.-N., Nguyen, T., & Le, N. D. T. (2023) · Infection Prevention in Practice · doi:10.1016/j.infpip.2023.100311 · Cited by 4
Why We Should Reexamine the “Golden Age” of Antibiotics in Social Context
Meagher, K. M. (2024) · The AMA Journal of Ethic · doi:10.1001/amajethics.2024.418 · Cited by 4
Kumar, C. K., Gleason, A., Parameswaran, G. G., Summan, A., Klein, E. Y., Laxminarayan, R., & Nandi, A. (2024) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2024.100498 · Cited by 4
Self-citationJi, W., Zhao, Y., Du, J., Zhao, H., McIver, D. J., Ye, D., Yan, K., Wei, X., & Fang, Y. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1475207 · Cited by 4
Analysis of hospital antimicrobial consumption to identify targets for antimicrobial stewardship
Yusef, D. H., Hayajneh, W. A., Bond, S. E., Lee-Milner, J., Al-Azzam, S. I., Issa, A. B., Jaradat, S. K., Gould, I. M., Conway, B. R., Hasan, S. S., et al. (2021) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2021.126 · Cited by 4
Setting a realistic AWaRe target for primary care antibiotic use in LMICs
Ingelbeen, B., Valia, D., Phanzu, D. M., van der Sande, M. A. B., & Tinto, H. (2023) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(23)00002-6 · Cited by 4
Roles of Biofilms in Biological Wastewater Treatment: An Insight
Malik, H. N., Kumari, A., Kumar, S., & Ray, S. (2024) · Water science and technology library · doi:10.1007/978-3-031-58331-5_15 · Cited by 3
Adebowale, O. O., Oyawole, O., Sanni, I., Odunfa, O., Oladejo, O. O., Folorunsho, E. O., Ajibola, A. B., & Nelson, G. U. (2025) · BMC Agriculture · doi:10.1186/s44399-025-00012-y · Cited by 3
Balapasheva, A., Smagulova, G., Mussina, A. Z., Dilmagambetov, D. S., Yermekbayeva, K. Z., Kelimberdiev, M. S., Kulnazarova, M. S., BALYMBETOVA, L., & Зиганшина, Л. Е. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1642830 · Cited by 3
Shrivas, V. L., Choudhary, A. K., Hariprasad, P., & Sharma, S. (2025) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2025.180431 · Cited by 3
Chalotra, R., Khajuria, N., Zaffer, I., & Singh, J. P. (2025) · Cureus · doi:10.7759/cureus.93812 · Cited by 5
Levitch, E., Matthews, L., Choi, E., Thushiyenthan, S., Hall, L., Tickner, J., & Dyda, A. (2025) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2025.10177 · Cited by 3
Maluleke, T. M., Maluleke, M. T., Ramdas, N., Golić-Jelić, A., Kurdi, A., Chigome, A., Campbell, S., Marković‐Peković, V., Schellack, N., Godman, B., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14121273 · Cited by 3
Predicting In-Hospital Antibiotic Use in the Medical Department: Derivation and Validation Study
Poran, I., Elbaz, M., Turjeman, ., Samuel, M. H., Eliakim‐Raz, N., Nashashibi, J., Paul, M., & Leibovici, L. (2022) · Antibiotics · doi:10.3390/antibiotics11060813 · Cited by 3
Мингазова, Э. Н., Иманкулова, А. С., Djumalieva, G. A., & Sulaimanova, D. (2023) · Problems of Social Hygiene Public Health and History of Medicine · doi:10.32687/0869-866x-2023-31-1-5-10 · Cited by 3
Totten, A. H., Xiao, L., Pol, B. J. V. D., Szychowski, J. M., Subramaniam, A., & Geisler, W. M. (2023) · Sexually Transmitted Diseases · doi:10.1097/olq.0000000000001843 · Cited by 3
Access to DTP-Based Combination Vaccines in Asia–Pacific Countries between 2019 and 2022
Ma, J., Sun, Y., Cui, Y., Dong, J., & Huang, Y. (2023) · Vaccines · doi:10.3390/vaccines12010033 · Cited by 3
Influencing Primary Care Antibiotic Prescription Behavior Using Financial Incentives
Ghamat, S., Araghi, M., Cipriano, L. E., & Silverman, M. E. (2024) · Production and Operations Management · doi:10.1177/10591478241264022 · Cited by 3
Potential activities to improve primary care prescribing of antibiotics across Africa
Chigome, A., Ramdas, N., Campbell, S., Gajdács, M., Sefah, I. A., Hango, E., Massele, A. Y., Godman, B., & Meyer, J. C. (2025) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2025.1634182 · Cited by 7
Maluleke, T. M., Maluleke, M. T., Golić-Jelić, A., Campbell, S., Marković‐Peković, V., Schellack, N., Ramdas, N., Godman, B., & Meyer, J. C. (2025) · Frontiers in Tropical Diseases · doi:10.3389/fitd.2025.1637843 · Cited by 4
Li, B., Li, B., Jia, Q., Cai, Y., Xiao, Y., & Yang, Z. (2025) · Journal of Contaminant Hydrology · doi:10.1016/j.jconhyd.2025.104741 · Cited by 3
Anhøj, J., Boel, J. B., Olesen, B. R., Bak, H. B., Hellesøe, A.-M. B., Thomsen, K., & Knudsen, J. D. (2022) · BMJ Open Quality · doi:10.1136/bmjoq-2022-002098 · Cited by 3
Kozak, М. R., Zelenina, O. M., Остапив, Д. Д., Skrypka, M., Samaryk, V., & Влизло, В. В. (2023) · Studia Biologica · doi:10.30970/sbi.1703.720 · Cited by 3
Antibiotic exposure associated with nighttime sleep duration and daytime sleepiness in newlyweds
Gu, L., Ni, Y., Wang, B., Kong, L., Yu, S., Tang, Y., Zhu, P., Shao, S., Tao, F., & Liu, K. (2023) · Environmental Science and Pollution Research · doi:10.1007/s11356-023-31475-8 · Cited by 3
Saito, R., Domon, H., Hiyoshi, T., Hirayama, S., Maekawa, T., Takenaka, S., Noiri, Y., Ikeda, A., Hirose, T., Sunazuka, T., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107384 · Cited by 3
Sefah, I. A., Quagraine, A. M., Kurdi, A. B., Mudenda, S., & Godman, B. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313019 · Cited by 4
Kasbi, Y., Sellami, F., Ferjani, A., Abbassi, A., & Boubaker, I. B.-B. (2025) · Antibiotics · doi:10.3390/antibiotics14020135 · Cited by 3
Mustafa, Z. U., Khan, A. H., Salman, M., Harun, S. N., Meyer, J. C., & Godman, B. (2025) · Advances in Human Biology · doi:10.4103/aihb.aihb_30_25 · Cited by 3
Tesař, T., Masaryková, L., Lehocká, Ľ., Porubcová, S., Cicova, M., & Wawruch, M. (2021) · Antibiotics · doi:10.3390/antibiotics10101180 · Cited by 3
Re-examining the notion of irrational antimicrobial prescribing in LMICs
Chaudhuri, S., & Pradhan, R. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30862-8 · Cited by 3
Morán-Díaz, J. R., Guevara‐Salazar, J. A., Cuevas‐Hernández, R. I., & Ferrara, J. G. T. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.1985459 · Cited by 3
Mahmoud, M. A., Meyer, J. C., Awaisu, A., Fadare, J. O., Fathelrahman, A. I., Saleem, F., Aljadhey, H. S., & Godman, B. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1124371 · Cited by 3
Masud, A., Walpola, R. L., Sarker, M., Kabir, A., Asaduzzaman, M., Islam, M. S., Mostafa, A. T., Akhtar, Z., Barua, M., & Seale, H. (2024) · Research Square · doi:10.21203/rs.3.rs-4357743/v1 · Cited by 3
Is the Incidence of Early‐Onset Adenocarcinomas in Aotearoa New Zealand Increasing?
Phang, R., Waddell, O., Dixon, W. G., Pearson, J. F., McCombie, A., & Frizelle, F. (2025) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.14184 · Cited by 2
Antibiotic consumption in 14 countries of sub-Saharan Africa: Findings from a retrospective analysis
de Jong, Y., Singhal, R., Alimi, Y. H., Kapoor, G., Sow, A., Matu, M., Shumba, E., Moreira, M., Batra, D., Laxminarayan, R., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0333842 · Cited by 2
Self-citationMunzhedzi, M., Chigome, A., Miljković, N., Moore, C. E., Campbell, S., Godman, B., & Meyer, J. C. (2025) · Advances in Human Biology · doi:10.4103/aihb.aihb_175_25 · Cited by 3
Acinetobacter baumannii: challenges presented by a drug-resistant pathogen
Goncalves, E. K., Ramos, L. A., Seibert, A., Ribeiro, L. M., McDuffie, S. L., Murray, M. C., & Fiester, S. E. (2026) · Frontiers in Bacteriology · doi:10.3389/fbrio.2025.1734537 · Cited by 4
The pharmacoeconomic revolution of bioenhancers: Redefining value in drug therapy
Tanisha, Tonk, M., Singh, I., Chauhan, S. B., Sharma, R. J., Swami, R., & Sachdeva, M. (2026) · Next research. · doi:10.1016/j.nexres.2026.101439 · Cited by 2
Kapoor, A., Dey, T., Kale, T. M., Kumar, A. A., Tak, V., Nag, V. L., & Shankar, M. (2026) · BMC Microbiology · doi:10.1186/s12866-026-04845-8 · Cited by 2
Sakhare, M. S., Kondawar, S. E., Agawane, G. L., & Sakate, S. S. (2026) · ChemistrySelect · doi:10.1002/slct.202507443 · Cited by 2
Khouja, T., Tadrous, M., & Suda, K. J. (2022) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkac274 · Cited by 2
Assan, A., Moldaliyev, I. S., Kerimbayeva, Z., Gaipov, A., Utepova, D., Magzumova, R., Tsoy, L., Issayev, A., & Aljofan, M. (2022) · Electronic Journal of General Medicine · doi:10.29333/ejgm/12576 · Cited by 2
Use of antibiotics and other treatments in Chinese adults with acute cough: An online survey
Hu, X.-Y. M., Xia, R., Moore, M. V., Stuart, B. L., Wen, L., Graz, B., Lai, L. Y. W., Liu, J., Fei, Y., & Willcox, M. L. (2022) · Integrative Medicine Research · doi:10.1016/j.imr.2022.100920 · Cited by 2
Piperacillin-tazobactam: prospects for use in real-world practice
Gomon, Y. М. (2023) · Real-World Data & Evidence · doi:10.37489/2782-3784-myrwd-36 · Cited by 2
Yamasaki, D., Ito, S., Ochiai, N., Yamaguchi, T., Suzuki, K., & Tanabe, M. (2024) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2024.08.006 · Cited by 2
Shafiurrahman, Hasan, S. S., Singh, K., Kumar, A., Suvaiv, Bano, J., Shahanawaz, M., Ahmad, S., & Kushwaha, S. P. (2024) · Anti-Infective Agents · doi:10.2174/0122113525318200240902062055 · Cited by 2
Sun, Z., Zhao, Y., Li, J.-K., Liu, H.-Y., Cao, W., Yu, F., Zhang, B.-K., & Yan, M. (2024) · Environmental Geochemistry and Health · doi:10.1007/s10653-024-02264-0 · Cited by 2
Wahlang, J. B., Syiem, R. P., Sarkar, C., Lyngdoh, N. M., Tiewsoh, I., Brahma, D. K., Surong, A., & Langstieh, A. J. (2024) · Journal of Family Medicine and Primary Care · doi:10.4103/jfmpc.jfmpc_952_24 · Cited by 4
Zhou, L., Zhao, Y., Zhu, J., Liu, J., Liang, G., Yang, Y., Han, G., & Yu, Z. (2024) · Drug Design Development and Therapy · doi:10.2147/dddt.s493980 · Cited by 2
Islam, M. F., Arka, P. B., Rohman, M., Hossain, M. S., Babu, M. R., Azhari, H. A., & Uddin, M. J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e41470 · Cited by 2
Afzal, S., Bajwa, M., Haroon, M. S., Arooj, H., Mushtaq, R. M. Z., & Saleem, Z. (2025) · Archives of Public Health · doi:10.1186/s13690-025-01720-2 · Cited by 4
Bleuse, A., Chabut, C., Roy, H., Lebel, D., Ovetchkine, P., Blackburn, J., & Bussières, J. (2021) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2021.08.012 · Cited by 2
Calle-Miguel, L., Pérez-Méndez, C., García-García, E., Moreno-Pavón, B., & Sánchez, G. S. (2022) · Children · doi:10.3390/children9030442 · Cited by 2
Report on Implementing Antimicrobial Stewardship Program for Long Term Antimicrobial Use
Park, H. J., Kim, J., Sohn, Y. M., Lee, J.-H., Lee, Y. S., Min, M. S., & Huh, K. (2022) · Journal of Korean Society of Health-System Pharmacists · doi:10.32429/jkshp.2022.39.2.005 · Cited by 2
Eckl, D. B., Landgraf, N., Hoffmann, A. K., Eichner, A., Huber, H., & Bäumler, W. (2022) · Photochemistry and Photobiology · doi:10.1111/php.13701 · Cited by 3
Hudson, B., Hagedoorn, N. N., Al-Busaidi, I. S., Bridgford, P., Gardiner, S. J., & Walls, T. (2023) · New Zealand Medical Journal · doi:10.26635/6965.5999 · Cited by 2
Omar, M., Kassem, E., Abu-Jabal, R., Mwassi, B., Cohen, D., & Muhsen, K. (2024) · Antibiotics · doi:10.3390/antibiotics13010064 · Cited by 3
Abbas, K., Ahmed, M., & Babar, Z. U. D. (2023) · Springer eBooks · doi:10.1007/978-3-030-50247-8_145-1 · Cited by 2
Abbas, K., Ahmed, M., & Babar, Z. (2023) · Springer eBooks · doi:10.1007/978-3-030-64477-2_145 · Cited by 2
Applications of Antibacterial Materials with Physiological Responsiveness in Wound Repair
周, 倩. (2023) · Material Sciences · doi:10.12677/ms.2023.134035 · Cited by 1
Hussain, S., Butt, T. E., Akram, H., & Fida, H. (2024) · Cleaner Water · doi:10.1016/j.clwat.2024.100046 · Cited by 1
Andreeva, I. V., Stetsiouk, О. U., Andreev, V. А., & Kozlov, R. S. (2024) · Clinical Microbiology and Antimicrobial Chemotherapy · doi:10.36488/cmac.2024.2.171-187 · Cited by 1
Point prevalence survey of antibiotic use in Mexican secondary care hospitals
Zumaya-Estrada, F., Alpuche-Aranda, C. M., Icelo, H. I. H., Neri-Estrada, F. D., Silva, V. M. C., Escoriza, H. E. Q., Garza–Ramos, U., & Saturno-Hernández, P. J. (2025) · PLoS ONE · doi:10.1371/journal.pone.0315925 · Cited by 1
Davis, M., Schermuly, A. C., Rajkhowa, A., Thursky, K., Warren, N., & Flowers, P. (2025) · Sociology of Health & Illness · doi:10.1111/1467-9566.70011 · Cited by 1
Nguyen, A., Heitmann, G. B., Mertens, A., Ashraf, S., Rahman, M. Z., Ali, S., Rahman, M., Arnold, B. F., Grembi, J. A., Lin, A., et al. (2025) · EClinicalMedicine · doi:10.1016/j.eclinm.2025.103147 · Cited by 1
Antibiotic Use in Pediatric Care in Ghana: A Call to Action for Stewardship in This Population
Sefah, I. A., BOSROTSI, D. K., Buabeng, K. O., Godman, B., & Bangalee, V. (2025) · Antibiotics · doi:10.3390/antibiotics14080779 · Cited by 2
Tigoi, C., Bourdon, C., Ngari, M. M., Musyimi, R., Timbwa, M., Mwaringa, S. M., Ngao, N., Maronga, C., Mburu, M., Ndirangu, A., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf487 · Cited by 1
Hillen, J. B., Stanford, T., Ward, M., Duszynski, K. M., Tong, X., Li, S. X., Wong, I. C. K., & Pratt, N. L. (2025) · Value in Health Regional Issues · doi:10.1016/j.vhri.2025.101173 · Cited by 1
Human Antimicrobial Use in Bangladesh: Five-Year Trend Analysis Including COVID-19 Pandemic Era
Yesmin, S. M. S., Chakma, P., Habiba, U., Larsen, A. R., Fusire, T., Wangmo, S., Sarkar, S., & Attauabi, M. (2025) · Antibiotics · doi:10.3390/antibiotics14090868 · Cited by 1
Akpan, M., Eshiet, U. I., Jackson, I. L., & Etim, E.-O. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-11918-y · Cited by 1
Otsubo, Y., Oda, R., Murata, Y., Sato, F., Akahoshi, S., Sakiyama, H., & Horikoshi, Y. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102885 · Cited by 1
Epling, J. W., & Rockwell, M. S. (2025) · Primary Care Clinics in Office Practice · doi:10.1016/j.pop.2025.09.006 · Cited by 1
Jamil, E., Aziz, M. M., Altaf, U., Altowayan, W. M., Alqasoumi, A. A., Arooj, H., Almutairi, M. S., & Saleem, Z. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1752211 · Cited by 1
Vaccines against antimicrobial resistance
Anderson, A. S. (2026) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.2025.0007 · Cited by 5
Mateescu, D.-M., Toma, A.-O., Gavrilescu, D.-M., Ilie, A. C., Florescu, E., Roșca, O., Oancea, C. I., Iurciuc, S., Mureșan, C.-O., & Enache, A. (2026) · Antibiotics · doi:10.3390/antibiotics15030240 · Cited by 1
Engineering non-ribosomal peptide synthesis: tuning the antibiotics engine of the microbial world
Butler, L., Awan, A. R., Ellis, T., & Akram, M. S. (2026) · Critical Reviews in Biotechnology · doi:10.1080/07388551.2026.2615819 · Cited by 1
Sun, X., Lin, Z., & Ni, S. (2026) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2026.142513 · Cited by 1
Chigome, A., Cook, A., Johnson, Y., Essack, S. Y., Brink, A., Mendelson, M., Campbell, S., Godman, B., & Meyer, J. C. (2026) · Antibiotics · doi:10.3390/antibiotics15060562 · Cited by 1
SÜFFERT, L. C., Pergher, E. A. B., de Abreu, H. S., Abreu, E. S., Beis, L. P. P., Padilha, I. H., Moraes, B. D. F., Passos, P. R. C., Visentini, L. M., Friedrich, F., et al. (2026) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2026.102877 · Cited by 1
Clinical Impact of Bloodstream Infections – Characterization, Risk factors and Outcome
Holmbom, M. (2021) · Linköping University medical dissertations · doi:10.3384/diss.diva-181406 · Cited by 1
Saxena, M., Kushwaha, J. P., Kulshreshtha, S., Kaur, G., & Singh, N. (2022) · Physics and Chemistry of Liquids · doi:10.1080/00319104.2022.2098295 · Cited by 1
Soltani, J., Versporten, A., Goossens, H., Pawels, I., Moradi, G., Yazdanifard, P., & Rashidzadeh, L. (2022) · Scientific Journal of Kurdistan University of Medical Sciences · doi:10.52547/sjku.27.5.108 · Cited by 1
Adsorption: a reliable solution for emerging contaminants removal
Sharifian, S., & KOLUR, N. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19211-1.00001-0 · Cited by 2
Evaluating drug use patterns among paediatric outpatients in Burundi
Manirakiza, A., Nyamu, D. G., Maru, S. M., Bizimana, T., & Nimpagaritse, M. (2024) · Journal of Pharmaceutical Policy and Practice · doi:10.1080/20523211.2024.2312369 · Cited by 1
Toxicological impacts of pharmaceuticals for human and animal on marine bivalves
Zhou, W., Huang, L., Zhang, W., Shi, W. M., & Liu, G. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-19117-6.00004-0 · Cited by 1
Aierken, A., Zhu, X., Wang, N., Zhang, J., Li, W., Wushouer, H., & Abudukeremu, K. (2024) · Antibiotics · doi:10.3390/antibiotics13080732 · Cited by 1
Mustafa, A. M., & Soor, T. A. H. (2025) · Journal of Biological Research - Bollettino della Società Italiana di Biologia Sperimentale · doi:10.4081/jbr.2025.13803 · Cited by 2
Miyawaki, A., Ladines-Lim, J. B., Sato, D., Kitajima, K., Linder, J. A., Fischer, M. A., Chua, K., & Tsugawa, Y. (2025) · BMJ Public Health · doi:10.1136/bmjph-2024-002364 · Cited by 1
Mitu, S. Y., Godman, B., Kumar, S., & Islam, S. (2025) · Advances in Human Biology · doi:10.4103/aihb.aihb_182_25 · Cited by 1
A Bottomless Well and Other Solutions
van den Brink, R. (2021) · Springer eBooks · doi:10.1007/978-3-030-70723-1_11 · Cited by 1
Nguyen, A., Heitmann, G. B., Mertens, A., Ashraf, S., Rahman, M. Z., Ali, S., Rahman, M., Arnold, B. F., Grembi, J. A., Lin, A., et al. (2024) · medRxiv · doi:10.1101/2024.10.13.24315425 · Cited by 1
Allel, K., Djukic, F., Thorn, M., Cook, A., Stephens, P. N., Chapman, S., Balachandran, A., Cook, A., Tayler, E., Cohn, J., et al. (2026) · medRxiv · doi:10.64898/2026.02.12.26346187 · Cited by 1
Self-citationCalle-Miguel, L., Méndez, C. P., García, E. G., Pavón, B. M., & Sánchez, G. S. (2021) · Research Square · doi:10.21203/rs.3.rs-555371/v1
Benkő, R., Matúz, M., Pető, Z., Weist, K., Heuer, O. E., Vlahović–Palčevski, V., Monnet, D. L., Galistiani, G. F., Hajdú, E., Blix, H. S., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3941046
A Snapshot of Antibiotic Resistances in Air Particulate of a Provincial Capital City, Indonesia
Sulfikar, S., Junarto, G., Syam, M. A., Efendy, A. Z., Sahrir, M., & Ningsih, H. (2022) · Jurnal Kimia VALENSI · doi:10.15408/jkv.v8i1.24559
Metadata
- Authors
- Klein, E. Y., Milkowska-Shibata, M., Tseng, K. K., Sharland, M., Gandra, S., Pulcini, C., & Laxminarayan, R.
- Affiliations
- Center for Disease Dynamics, Economics & Policy (US)
- St George's, University of London (GB)
- Washington University in St. Louis (US)
- Corresponding author
- Klein, Eili Y
- Venue
- The Lancet Infectious Diseases
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 21
- Issue
- 1
- Pages
- 107-115
- ISSN
- 1473-3099 (ISSN-L)
- OpenAlex
- W3044776476
- Cited by
- 500
- References
- 26
- Citations by year
- 2026: 61 · 2025: 95 · 2024: 110 · 2023: 94 · 2022: 78 · 2021: 58
- FWCI
- 34.82
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- St George's Online Research Archive (St George's University of London) (acceptedVersion)
- HAL (submittedVersion)
- Funders
- Centers for Disease Control and Prevention
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Pharmaceutical Economics and Policy
- Keywords
- antibiotic use, AWaRe classification, antibiotic access, antibiotic stewardship, pharmaceutical sales data, Watch antibiotics, low- and middle-income countries, high-income countries, defined daily doses, antimicrobial resistance, cross-national comparison
- MeSH terms
- Antimicrobial Stewardship, Anti-Bacterial Agents, Commerce, Developing Countries, Drug Utilization, Pharmaceutical Preparations, Forecasting, Humans, World Health Organization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review